Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-Finding Study of Phosphatidylcholine in Ulcerative Colitis
NCT00259558Phase 2Completed
- Sponsor
- Heidelberg University
- Start
- Apr 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of phosphatidylcholine in ulcerative colitis (UC), sponsored by Heidelberg University. Started Apr 2003; status: completed.
02
Drugs
phosphatidylcholine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00259558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00259558.